Les Enphants to Resume Normal Trading Method from May 20

Les Enphants Co., Ltd. has announced that its listed securities will resume the normal trading method starting from May 20, 115 (ROC calendar). This follows the Taiwan Stock Exchange's confirmation that the company's net worth has exceeded one-half of its stated share capital for the last two reporting periods, thereby resolving the issue that previously led to its classification as an altered trading method stock.
財務,證券市場NQ 75/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 19, 2026 at 06:31
  • 🔍 Collected: May 19, 2026 at 06:31 (0 min after Published)
  • 🤖 AI Analyzed: May 19, 2026 at 06:49 (17 min after Collected)
Publication Date: 1150519 Spokesperson Date: 1150518 Spokesperson Time: 171234 Company Code: 2911 Company Name: Les Enphants Subject: Announcement regarding the resumption of normal trading method for the company's listed securities from May 20, 115 (ROC calendar). Compliant Clause: Article 1 Date of Occurrence: 1150518 Explanation: 1. Date of stock status restoration announced by the Stock Exchange: 115/05/18 2. The operating rules clause cited and reason for the stock status restoration announced by the Stock Exchange: The company was previously subject to an altered trading method for its listed securities due to circumstances specified in Article 49, Paragraph 1, Subparagraph 1 of the Operating Rules of the Taiwan Stock Exchange Corporation. Subsequently, the company's latest two publicly announced and filed financial reports showed that its net worth reached over one-half of its stated share capital. The original reason for the altered trading method has ceased to exist, and there are no other circumstances requiring it to be an altered trading method stock. Therefore, the trading method for its listed securities is restored. 3. Announcement Content: The Stock Exchange has announced that the company's listed securities will resume the normal trading method from May 20, 115 (ROC calendar). 4. Date of Stock Status Restoration: 115/05/20 5. Other remarks: None.